Definitive Healthcare Corp. DH
0.95
(0.06)
(5.94%)
as of 25 Sep
- Market cap
- $146.3M
- P/E
- 0.0×
Follow DH
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
1.74 | 1.27 | 0.54 | 0.38 | |
P/FCF ratio |
11.70 | 8.26 | 4.76 | 3.07 | |
P/Operating CF |
26.86 | 112.53 | 11.13 | 7.67 | |
P/B ratio |
1.08 | 0.81 | 0.68 | 0.47 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.66 | 1.20 | 0.48 | 0.28 | |
EV/EBITDA |
8.35 | 6.55 | 2.38 | 1.46 | |
EV/Operating CF |
6.80 | 5.39 | 2.89 | 1.57 | |
EV/FCF |
11.17 | 7.83 | 4.19 | 2.27 | |
Quick Ratio |
1.43 | 1.49 | 1.55 | 1.66 | |
Current Ratio |
1.60 | 1.64 | 1.75 | 1.86 | |
Net Debt/EBITDA |
(2.00) | (1.48) | (1.17) | (2.10) | |
Debt/Assets |
22.10% | 22.41% | 31.62% | 32.33% | |
Debt/Equity |
0.43 | 0.43 | 0.85 | 0.86 | |
Asset Turnover |
0.25 | 0.26 | 0.36 | 0.37 | |
Operating CF/Net income |
(1.06) | (0.29) | (0.08) | (2.11) | |
Capex/Depreciation |
(0.13) | (0.12) | (0.01) | (0.17) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
12.58% | 16.18% | 11.62% | 12.24% | |
Selling, General and Administrative Expense of Revenue |
54.53% | 56.00% | 56.61% | 54.29% | |
Intangible Assets out of Total Assets |
0.63 | 0.60 | 0.46 | 0.45 | |
Share Based Compensation of Revenue |
11.13% | 13.26% | 9.33% | 9.52% | |
Graham Net Nets |
(0.28) | (0.32) | (0.61) | (0.78) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(41.13%) | (43.55%) | (131.71%) | (192.77%) | |
Free Cash Flow Yield |
8.55% | 12.11% | 21.02% | 32.52% | |
Revenue per Share |
0.58 | 0.58 | 0.53 | 0.52 | |
Operating CF per Share |
0.15 | 0.03 | 0.11 | 0.11 | |
Capex per Share |
(0.02) | (0.04) | (0.03) | (0.03) | |
Free Cash Flow per Share |
0.13 | (0.02) | 0.08 | 0.08 | |
Cash per Share |
1.79 | 1.70 | 1.70 | 1.74 | |
Shareholders Equity per Share |
3.75 | 3.55 | 1.82 | 1.78 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.75 | 3.55 | 1.82 | 1.78 | |
Free Cash Flow |
13.41 | (1.72) | 8.36 | 8.51 | |
Working Capital |
92.44 | 100.82 | 105.35 | 111.03 | |
Capital Expenditures |
(2.28) | (4.44) | (3.20) | (2.94) | |
Net Current Asset Value |
(119.54) | (98.89) | (78.28) | (68.87) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.04 | 0.07 | 0.06 | 0.05 | |
Net Profit Margin |
(24.71%) | (15.14%) | (247.85%) | (9.82%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
35.06 | 52.61 | 40.93 | 34.24 | |
Average Payables |
9.27 | 7.18 | 7.12 | 6.21 | |
Average Assets |
968.59 | 912.44 | 661.70 | 633.49 | |
Average Common Equity |
542.62 | 493.09 | 313.30 | 299.55 |
Columns are period end dates